Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral progesterone vs placebo to reduce recurrent preterm labor
IRCT201710079014N192Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Preterm labor (PTL) comparing Oral progesterone with Placebo (2 arms). Primary endpoint: Incidence of recurrent preterm labor. Started Jan 2017; status: completed.
02
Drugs
progesterone
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on IRCT201710079014N192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201710079014N192.